临床肝胆病杂志2024，Vol.40Issue(8)：1567-1574,8.DOI:10.12449/JCH240810
《2024年欧洲肝病学会/欧洲糖尿病学会/欧洲肥胖症学会临床实践指南:代谢相关脂肪性肝病的管理》摘译
An excerpt of EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease in 2024
倪文婧 1耿楠 2白雪 2李婕1
作者信息
- 1. 南京中医药大学鼓楼临床医学院,南京 210008||南京大学医学院附属鼓楼医院感染性疾病科,南京 210008
- 2. 南京大学医学院附属鼓楼医院感染性疾病科,南京 210008
- 折叠
摘要
Abstract
In June 2024,the European Association for the Study of the Liver,the European Association for the Study of Diabetes,and the European Association for the Study of Obesity jointly released the latest edition of clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease(MASLD),which comprehensively elaborates on the definition,prevalence rate,natural disease history,screening,diagnosis,and treatment of MASLD and proposes 33 statements and 72 recommendations.This article gives an excerpt of the key points in this document.关键词
脂肪肝/欧洲/诊疗准则Key words
Fatty Liver/Europe/Practice Guideline引用本文复制引用
倪文婧,耿楠,白雪,李婕..《2024年欧洲肝病学会/欧洲糖尿病学会/欧洲肥胖症学会临床实践指南:代谢相关脂肪性肝病的管理》摘译[J].临床肝胆病杂志,2024,40(8):1567-1574,8.
